Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Severe stomach problems, including delayed gastric emptying (gastroparesis), have been experienced by some people who have taken Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Saxenda, Trulicity and Victoza
During the first three quarters of 2025, Mounjaro sales nearly doubled (up 94%) from $8.010 billion to $15.558 billion, including $6.515 billion garnered in Q3 (more than double a year earlier)while Zepbound sales tripled from $3.018 billion to $9.281 billion, including $3.588 billion racked up in the July-September quarter, nearly triple (185%) Q3 2024
Mean weight loss was 15.3 kg (33.7 lb) among teens on semaglutide, while those on placebo gained 2.4 kg (5.3 lb). Based on this data, Wegovy is now FDA-approved in kids ages 12-17
Manufactured by Eli Lilly, Trulicity belongs to a class of drugs known as GLP-1 receptor agonists
US$ 25.04
US$ 28.48
US$ 22.14
US$ 28.12
US$ 28.20
US$ 25.19
US$ 20.32
US$ 24.85
US$ 21.21
US$ 24.21
